More than 75% of the cohort started a TNF inhibitor during the selected time frame. For the rest, JAK inhibitors were the ...

Listen to this article Arthritis is often simplified as joint pain or disease. While accurate, this barely conveys the ...

Achy hips are all too common as the years pass. About 1 in 4 adults will have hip osteoarthritis (OA) by age 85, according to ...

Arthritis, which typically causes stiffness, swelling, pain and inflammation in a joint, is the most common disabling ...

Nearly 461,000 people receive Attendance Allowance for arthritis, making it the most-claimed health condition by people over ...

Hip and knee pain can significantly impact daily life for millions of people. Whether it’s the result of age, injury, or ...

If left untreated, hip dysplasia can be debilitating and can lead to chronic pain and arthritis later in life.

The US Food and Drug Administration has approved bimekizumab -bkzx (Bimzelx; UCB) for adult patients with active psoriatic ...

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...

Our shoulders are the workhorse of the body, which lets us lift, reach, and throw. However, there is always a possibil ...

Arthritis, which typically causes stiffness, swelling, pain and inflammation in a joint, is the most common disabling ...

The Department for Work and Pensions (DWP) has revealed the most common disabilities and health conditions that are leading ...